Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients

NCT02437071 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: Radiotherapy
PROCEDURE: Radiofrequency ablation

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]